FILTER

FILTERED INTERVIEW RESULTS

Shankar Musunuri

CHAIRMAN, CEO & CO-FOUNDER, OCUGEN
Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.

Ian Cooper

CEO, FAMAR
Famar explains how it will continue develop capabilities so as to accompany its customers through clinical phases with clinical batches, scale-up, and ultimately manufacturing and packaging.

Brian Frenzel

PRESIDENT & CEO, TOSK
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.

Ramin Cyrus

VICE PRESIDENT MARKETING, LONZA CAPSULES AND HEALTH INGREDIENTS
Lonza Capsules and Health Ingredients comments on market trends.

Vivek Sharma

CEO, ADARE PHARMA SOLUTIONS
Adare Pharma Solutions explains how it is expanding its range as a leading technology-driven CDMO.

John Huang

CEO, THEWELL BIOSCIENCE
TheWell Bioscience is a biomedical technology company providing innovative 3D cell platforms for drug discovery, cell therapy and personalized medicine.

Cosimo Lenti

BUSINESS DIRECTOR, DIATHEVA
Diatheva promotes biotechnological innovation by providing high-value customized diagnostic kits and solutions.

Gilda D'Incerti

CEO AND FOUNDER, PQE GROUP
PQE Group explains its imperative to expand rapidly apace with the global life science industry.

Robert Bloder

CHIEF BUSINESS OFFICER, ASCENDIA PHARMACEUTICALS
Ascendia Pharmaceuticals recounts the requirements to succeed in the CDMO space.

Jigar Raythatha

PRESIDENT & CEO, CONSTELLATION PHARMACEUTICALS
Constellation Pharmaceuticals explains its therapy for myelofibrosis and introduces its discovery engine.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Pharmaceuticals & Biopharmaceuticals 2021

PARTNER EVENTS